Thrive Partners Vii Growth Gp, Buys 420,819 Shares of Oscar Health, Inc. (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) Director Thrive Partners Vii Growth Gp, bought 420,819 shares of the stock in a transaction dated Tuesday, November 12th. The stock was purchased at an average cost of $13.68 per share, for a total transaction of $5,756,803.92. Following the acquisition, the director now owns 5,452,081 shares of the company’s stock, valued at approximately $74,584,468.08. This represents a 8.36 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Oscar Health Stock Performance

Shares of OSCR stock opened at $15.45 on Friday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.73. The stock has a market cap of $3.74 billion, a PE ratio of -251.12, a P/E/G ratio of 12.49 and a beta of 1.67. Oscar Health, Inc. has a 1 year low of $6.93 and a 1 year high of $23.79. The stock has a fifty day moving average price of $18.28 and a 200 day moving average price of $18.30.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The business had revenue of $2.42 billion during the quarter, compared to analysts’ expectations of $2.33 billion. During the same quarter in the prior year, the firm earned ($0.29) earnings per share. Oscar Health’s quarterly revenue was up 68.3% on a year-over-year basis. Sell-side analysts forecast that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Institutional Trading of Oscar Health

Several large investors have recently modified their holdings of OSCR. Wealth Enhancement Advisory Services LLC grew its holdings in Oscar Health by 7.5% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock valued at $255,000 after buying an additional 844 shares during the last quarter. American International Group Inc. boosted its stake in shares of Oscar Health by 1.3% during the first quarter. American International Group Inc. now owns 79,411 shares of the company’s stock valued at $1,181,000 after acquiring an additional 1,009 shares during the last quarter. Summit Trail Advisors LLC increased its position in Oscar Health by 5.4% during the 2nd quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company’s stock worth $329,000 after purchasing an additional 1,065 shares in the last quarter. KBC Group NV raised its stake in Oscar Health by 41.2% in the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after purchasing an additional 1,328 shares during the last quarter. Finally, Arizona State Retirement System lifted its holdings in Oscar Health by 3.7% in the 2nd quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock valued at $602,000 after purchasing an additional 1,351 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Finally, UBS Group assumed coverage on Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $22.93.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.